Join to View Full Profile
127 S San Vicente BlvdLos Angeles, CA 90048
Phone+1 310-423-6472
Fax+1 310-967-0601
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Duaa Jabari, MD is a board certified neurologist in Los Angeles, California. He is currently licensed to practice medicine in California, Missouri, and Texas.
Education & Training
University of Kansas School of MedicineFellowship, Neuromuscular Medicine (Neurology), 2015
University of Texas Health Science Center at HoustonResidency, Neurology, 2011 - 2014- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2010 - 2011
University of Tichreen Faculty of MedicineClass of 2004
Certifications & Licensure
TX State Medical License 2020 - 2027
CA State Medical License 2022 - 2026
MO State Medical License 2022 - 2026
KS State Medical License 2014 - 2025
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Publications & Presentations
PubMed
- 3 citationsA 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.Salman Bhai, Todd Levine, Dan Moore, Robert Bowser, Andrew J Heim
Muscle & Nerve. 2025-01-01 - 14 citationsSafety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, pha...Michael Benatar, Thomas Hansen, Dror Rom, Marie A Geist, Thomas Blaettler
The Lancet. Neurology. 2024-07-01 - 357 citationsSafety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Peric
The Lancet. Neurology. 2021-07-01
Press Mentions
Teacher and Pathologist Joins Neuromuscular TeamMay 13th, 2024
